Department of Gastroenterology, Klinikum Ludwigsburg, Ludwigsburg, Germany.
novineon CRO, Tuebingen, Germany.
Am J Gastroenterol. 2020 Dec;115(12):1998-2006. doi: 10.14309/ajg.0000000000000795.
Endoscopic full-thickness resection (EFTR) is a powerful option for resection of colorectal lesions not amenable to conventional endoscopic resection. The full-thickness resection device (FTRD) allows clip-assisted EFTR with a single-step technique. We report on results of a large nationwide FTRD registry.
The "German colonic FTRD registry" was created to further assess efficacy and safety of the FTRD System after approval in Europe. Data were analyzed retrospectively.
Sixty-five centers contributed 1,178 colorectal FTRD procedures. Indications for EFTR were difficult adenomas (67.1%), early carcinomas (18.4%), subepithelial tumors (6.8%), and diagnostic EFTR (1.3%). Mean lesion size was 15 × 15 mm and most lesions were pretreated endoscopically (54.1%). Technical success was 88.2% and R0 resection was achieved in 80.0%. R0 resection was significantly higher for subepithelial tumor compared with that for other lesions. No difference in R0 resection was found for smaller vs larger lesions or for colonic vs rectal procedures. Adverse events occurred in 12.1% (3.1% major events and 2.0% required surgical treatment). Endoscopic follow-up was available in 58.0% and showed residual/recurrent lesions in 13.5%, which could be managed endoscopically in most cases (77.2%).
To date, this is the largest study of colorectal EFTR using the FTRD System. The study demonstrated favorable efficacy and safety for "difficult-to-resect" colorectal lesions and confirms results of previous studies in a large "real-world" setting. Further studies are needed to compare EFTR with other advanced resection techniques and evaluate long-term outcome.
内镜全层切除术(EFTR)是一种强大的选择,用于切除无法进行常规内镜切除的结直肠病变。全层切除器械(FTRD)允许使用单次技术进行夹辅助 EFTR。我们报告了一项大型全国性 FTRD 登记研究的结果。
“德国结肠 FTRD 登记”是在欧洲批准后进一步评估 FTRD 系统的疗效和安全性而创建的。数据进行了回顾性分析。
65 个中心贡献了 1178 例结直肠 FTRD 手术。EFTR 的适应证为困难腺瘤(67.1%)、早期癌(18.4%)、黏膜下肿瘤(6.8%)和诊断性 EFTR(1.3%)。平均病变大小为 15×15mm,大多数病变在内镜下进行预处理(54.1%)。技术成功率为 88.2%,R0 切除率为 80.0%。黏膜下肿瘤的 R0 切除率明显高于其他病变。对于较小的病变与较大的病变或直肠与结肠手术,R0 切除率无差异。12.1%(3.1%为主要事件,2.0%需要手术治疗)发生不良事件。58.0%可获得内镜随访,显示 13.5%残留/复发病变,大多数情况下可通过内镜治疗(77.2%)。
迄今为止,这是使用 FTRD 系统进行的最大规模的结直肠 EFTR 研究。该研究证明了“难以切除”结直肠病变的良好疗效和安全性,并在大型“真实世界”环境中证实了先前研究的结果。需要进一步的研究来比较 EFTR 与其他先进的切除技术,并评估长期结果。